We are live on ! Find out more
MBOT icon

Microbot Medical

39 hedge funds and large institutions have $16.1M invested in Microbot Medical in 2014 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

28% more capital invested

Capital invested by funds: $12.6M → $16.1M (+$3.49M)

5% more funds holding

Funds holding: 3739 (+2)

0% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 10

Holders
39
Holders Change
+2
Holders Change %
+5.41%
% of All Funds
1.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
10
Reduced
10
Closed
5
Calls
Puts
Net Calls
Net Calls Change

MBOT Hedge Fund Activity: Q3 2014 in Review

39 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2014, worth a combined $16.1M — up 28% from $12.6M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new MBOT positions and 5 closed out — a net gain of 2 holders — while 10 added to existing stakes and 10 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $7.86M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $551K sold.

  • 39 institutional investors held Microbot Medical (MBOT) as of Q3 2014, up from 37 in Q2 2014.
  • Funds reported $16.1M of Microbot Medical stock for Q3 2014, up 28% quarter-over-quarter.
  • 7 funds opened new Microbot Medical positions in Q3 2014 and 5 closed out, a net change of +2 holders.
  • The largest Microbot Medical buyer in Q3 2014 was Sabby Management, an estimated $7.86M added.
  • The largest Microbot Medical seller in Q3 2014 was Perceptive Advisors, an estimated $551K sold.

Based on aggregated 13F filings for Q3 2014.